2021-01-05,"ALERT: Halper Sadeh LLP Investigates CPAH, CBLI, QEP, SNCA; Shareholders Are Encouraged to Contact the Firm"
2021-01-03,"Lifshitz Law Firm, P.C. Announces Investigation of HMSY, SNCA, SPWH and TCF"
2020-12-30,"SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers  UROV, EIGI, SNCA, CLCT"
2020-12-28,"SHAREHOLDER ALERT: WeissLaw LLP Reminds ZAGG, PS, TCF, and SNCA Shareholders About Its Ongoing Investigations"
2020-12-28,"SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - RESI, NAV, SNCA, TLRY, CLCT"
2020-12-24,"Lifshitz Law Firm, P.C. Announces Investigation of ANCN, BEAT, HMSY, SNCA, SPWH, TCP, TRP, TLRY, and APHA"
2020-12-24,"ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers  ALSK, NAV, SNCA, TLRY"
2020-12-23,"SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Seneca Biopharma, Inc. - SNCA"
2020-12-19,"SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - BEAT, SNCA, BBIO, TLRY, NEOS"
2020-12-18,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Seneca Biopharma, Inc. Merger"
2020-12-18,"ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Seneca Biopharma, Inc."
2020-12-17,"SHAREHOLDER ALERT: WeissLaw LLP Investigates Seneca Biopharma, Inc."
2020-12-17,"Seneca Merger Investigation: Halper Sadeh LLP Announces Investigation into Whether the Merger of Seneca Biopharma, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm  SNCA"
2020-12-17,Leading BioSciences and Seneca Biopharma Announce Merger
2020-12-15,Seneca Biopharma Granted 180-Day Extension by NASDAQ to Regain Compliance with Bid Price Rule
2020-11-10,Seneca Biopharma Reports 2020 Third Quarter Results
2020-09-10,"Seneca Biopharma, Inc. Announces Completion of Phase II Clinical Study in China for the Treatment of Ischemic Stroke"
2020-09-02,Letter from Seneca Biopharma's Executive Chairman
2020-08-13,Seneca Biopharma Reports 2020 Second Quarter Results
2020-08-10,"Seneca Biopharma, Inc. Announces Adjournment of Annual Meeting of Stockholders"
2020-05-27,Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering
2020-05-22,Seneca Biopharma Reports Receipt of Warrant Exercise Proceeds
2020-05-22,Seneca Biopharma Announces Pricing of $5 Million Registered Direct Offering Priced At-the-Market
2020-05-15,Seneca Biopharma Reports 2020 First Quarter Results
2020-04-09,Seneca Biopharma Announces Results of Meeting with FDA Regarding the Design of Phase 3 Trial for NSI-566 in ALS
2020-04-07,Seneca Biopharma Announces Update on Phase II Clinical Trial Underway in China for the Treatment of Ischemic Stroke
2020-04-03,"Seneca Biopharma, Inc. Announces the Completion of Stem Cell Manufacturing Facility in China"
2020-04-01,Seneca Biopharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
2020-04-01,Seneca Biopharma Announces Executive Appointments and Key Promotion
2020-03-27,"Seneca Biopharma, Inc. Reports Year End 2019 Fiscal Results"
2020-02-13,"INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Seneca Biopharma, Inc. for Potential Securities Violations and Breach of Fiduciary Duty Claims"
2020-01-17,Seneca Biopharma Announces Exercise of Warrants for $7.55 Million Gross Proceeds Priced At-the-Market
2020-01-10,Seneca Biopharma Announces Presentations at Both Sachs Associates 3rd Annual Neuroscience Innovation Forum & Biotech Showcase 2020
